Urvi A. Shah, MD, MS, is a hematologist-oncologist, lifestyle medicine specialist, and physician-scientist. She serves as an Assistant Attending Physician in the Myeloma Service within the Division of Hematologic Malignancies at Memorial Sloan Kettering Cancer Center and is an Assistant Professor of Medicine at Weill Cornell Medicine. Her clinical practice focuses on hematologic malignancies and precursor blood disorders, cancer immunotherapy and targeted treatments, and lifestyle-based supportive care and survivorship. Dr. Shah’s research centers on nutritional oncology, cancer metabolism, and the gut microbiome, with a particular interest in how modifiable lifestyle factors influence immune health and disease progression. She leads innovative clinical and translational research in these areas as principal investigator of the NUTRIVENTION trial series. Her achievements include the NCI K12 Career Development Award and selection as an EIAP Scholar, the ASH Scholar Award and CRTI Award, the International Myeloma Society Career Development Award, the ECOG-ACRIN Young Investigator Translational Research Award, the Clinical Cancer Research Early Career Award, the Celgene Future Leaders in Hematology Award, and the Henry Moses Research Award. She is also a frequent invited speaker, panelist, and session chair at national and international hematology and oncology meetings. Dr. Shah earned her medical degree from Grant Medical College, completed her Internal Medicine residency at Tufts Medical Center, and pursued fellowship training in Hematology and Medical Oncology at Montefiore Medical Center/Albert Einstein College of Medicine. She subsequently completed a fellowship in Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center/Parker Institute for Cancer Immunotherapy and also holds a Master of Science in Clinical and Translational Cancer Research.
Assistant Professor
Medical School
2005 – 2011
Residency
2012 – 2015
Fellowship
2015 – 2018